C3 and COVID-19: The serum levels of C3 and C4 were also significantly lower in acute-phase sera compared to the convalescent sera of the same patients and significantly lower than in the NHS controls, supporting the hypothesis that acute-phase sera are hypocomplementaemic due to complement consumption in the early phase of severe COVID-19 (Figures 4B, C).